Late Preterm Infant (Near-Term)
Attributes to meet: PDF: Download File, Fact Sheets
Download File: condition met
Fact Sheet, 2023
A late preterm infant is a baby that is born between 34-36 (almost 37) weeks of pregnancy. This fact sheet provides information about some health problems that might affect a late preterm infant, things that caregivers and parents should watch for, and some questions to be discussed before leaving the hospital.
Related products
-
HIV, Pregnancy, and Tobacco Use
Poster, 2023
This poster explains that for women living with HIV, smoking tobacco during pregnancy can increase the chances that HIV will be passed to the baby. Supports are listed to help pregnant women and those planning a pregnancy to quit or reduce their tobacco use.
SKU: 7-517 -
HIV: Healthy Pregnancies and Healthy Babies
Booklet, 2018
This booklet is designed for people living with HIV who are planning a pregnancy or are already pregnant. Topics include basic HIV and HIV treatment information, how to stay healthy before and during pregnancy, unique issues that may face women living with HIV, and where to go for more information and support. The booklet is an update to the previous HIV and pregnancy-related pamphlets provided by the Saskatchewan Prevention Institute.
SKU: 7-005 -
Perinatal Transmission of HIV: Prevention, Treatment, and Education
Report, Updated 2026
Saskatchewan continues to see high rates of new cases of human immunodeficiency virus (HIV) infection in comparison to the rest of Canada. A large number of these new cases are being identified in women of childbearing age.
Recognizing the importance of understanding HIV in the context of pregnancy, the Saskatchewan Prevention Institute conducted a review of the literature in this area. The review includes findings and recommendations on perinatal transmission, transmission prevention, barriers to prevention, and health promotion around these topics.
SKU: 7-501 -
Neonatal Abstinence Syndrome Literature Review
Report, 2020
Neonatal abstinence syndrome (NAS) is a condition whereby some infants exposed to particular substances in utero experience a variety of postnatal withdrawal symptoms shortly after birth. Increased rates of NAS have been reported in Canada over the past decade. This review provides information about the development and effects of NAS, modes of assessment, treatment options (both pharmacological and non-pharmacological), care guidelines for parents and caregivers, and primary prevention strategies.
SKU: 2-905